Image For Activity Cover
Pediatric Half and Half MAT Waiver Training
Educational Objectives

This program will provide an array of background and clinical information concerning the pharmacological use of buprenorphine for the treatment of opioid addiction. At the conclusion of this course, participants will have a working knowledge of the following:

  • Describe the fundamentals of office-based opioid treatment including the treatment of co-occurring psychiatric illness.
  • Explain the process of opioid use disorder (OUD) assessment, and buprenorphine induction, stabilization and maintenance.  
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Apply for a Data 2000 Waiver to begin utilizing buprenorphine in the treatment of patients with OUD.


Target Audience
This activity will assist physicians, nurse practitioners, and physician assistants who wish to apply for a waiver to prescribe buprenorphine for the treatment of opioid use disorders.
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

8-Hour DEA Training Inquiries, email PCSS-MOUD.


Powered By